Notice

National Center for Advancing Translational Sciences; Notice of Closed Meeting

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number	2025-04595
Type	Notice
Published	Mar 19, 2025
Effective Date	-
RIN	-
Docket ID	-
Text Fetched	Yes

Agencies & CFR References

Agency Hierarchy:

Health and Human Services Department→National Institutes of Health

CFR References:

None

Linked CFR Parts

Part	Name	Agency
No linked CFR parts

Paired Documents

Type	Proposed	Final	Method	Conf
No paired documents

External Links

View on FederalRegister.gov Search Regulations.gov

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

Incorporate requirements by reference (IBR) to external documents
Are procedural notices without substantive obligations
Contain only preamble/explanation without regulatory text

▼ Full Document Text (262 words · ~2 min read)

Text Preserved

<NOTICE>
 
 DEPARTMENT OF HEALTH AND HUMAN SERVICES 
 <SUBAGY>National Institutes of Health</SUBAGY>
 <SUBJECT>National Center for Advancing Translational Sciences; Notice of Closed Meeting</SUBJECT>
 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. 
 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The cooperative agreement applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the cooperative agreement applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 
 <EXTRACT>
 
 <E T="03">Name of Committee:</E>
 National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS CTSA UM1 Review Special Emphasis Panel.
 
 
 <E T="03">Date:</E>
 April 21, 2025.
 
 
 <E T="03">Time:</E>
 10:00 a.m. to 5:00 p.m.
 
 
 <E T="03">Agenda:</E>
 To review and evaluate cooperative agreement applications.
 
 
 <E T="03">Address:</E>
 National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Rockville, MD 20892 (Virtual).
 
 
 <E T="03">Contact Person:</E>
 Marilyn Moore-Hoon, Ph.D., Scientific Review Officer, Scientific Review Branch, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Suite 1E504, Bethesda, MD 20892, (301) 827-9087, 
 <E T="03">mooremar@mail.nih.gov</E>
 .
 
 <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)</FP>
 </EXTRACT>
 <SIG>
 <DATED>Dated: March 14, 2025.</DATED>
 <NAME>David W. Freeman,</NAME>
 Supervisory Program Analyst, Office of Federal Advisory Committee Policy. 
 </SIG>
 
 <FRDOC>[FR Doc. 2025-04595 Filed 3-18-25; 8:45 am]</FRDOC>
 </NOTICE>
							

This text is preserved for citation and comparison.

PDF Official Version